Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents

JACC Cardiovasc Interv. 2008 Jun;1(3):279-85. doi: 10.1016/j.jcin.2008.01.009.

Abstract

Objectives: This study sought to determine vasomotor functional responses of conduit coronary artery distal to bare-metal stents (BMS), polymer-only stents (POLY), and sirolimus-eluting stents (SES) in a clinically relevant animal model.

Background: Drug-eluting stents (DES) reduce in-stent restenosis, and also affect neointima formation and vascular remodeling in downstream coronary segments. Whether distal artery vasomotor function is also influenced by DES has not been determined.

Methods: Pigs (n = 12) received coronary stent implants, and hearts were harvested at 1 month. Arterial segments >or=15 mm distal to stents were excised and studied in an organ-chamber apparatus. Endothelium-dependent and endothelium-independent relaxation and contraction to classical agonists were measured.

Results: The SES showed increased lumen area and reduced neointima; abnormal vasomotor function of conduit arteries distal to SES also was observed. Contraction to endothelin-1 was significantly enhanced for SES compared with both BMS and POLY. Endothelium-dependent relaxation to a maximal dose of substance P was attenuated for SES compared with both BMS and POLY (46 +/- 6% vs. 71 +/- 3% and 78 +/- 3%, respectively, p < 0.001). Endothelium-independent relaxation to sodium nitroprusside was potentiated for SES, compared with BMS and POLY (100 +/- 5% vs. 69 +/- 7% and 77 +/- 5%, respectively, p = 0.02).

Conclusions: Stent-based local delivery of sirolimus profoundly inhibited neointima formation but caused vasomotor dysfunction in distal conduit vessel segments. These observations suggest that distal coronary vasospasm may be more readily evoked in the presence of DES and contribute to pathophysiological sequela.

Publication types

  • Comparative Study

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / instrumentation*
  • Animals
  • Cardiovascular Agents / administration & dosage*
  • Coronary Vasospasm / etiology
  • Coronary Vasospasm / physiopathology
  • Coronary Vessels / drug effects
  • Coronary Vessels / pathology
  • Coronary Vessels / physiopathology*
  • Dose-Response Relationship, Drug
  • Drug-Eluting Stents*
  • Female
  • Male
  • Metals
  • Models, Animal
  • Prosthesis Design
  • Sirolimus / administration & dosage*
  • Stents*
  • Sus scrofa
  • Thrombosis / etiology
  • Thrombosis / physiopathology
  • Time Factors
  • Vasoconstriction* / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Cardiovascular Agents
  • Metals
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Sirolimus